MAPT and Alzheimer disease: Indeed M1 receptors, in addition to their role in the modulation of cholinergic neurotransmission, have the potential to regulate the processing of pathological amyloid and tau, thus alleviating the major hallmarks of AD and extending the lifespan of terminally sick mice (Scarpa et al. 2020).